D. E. Shaw & Co., Inc. - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 58 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$291,024
-55.3%
60,504
-62.2%
0.00%
-100.0%
Q1 2023$650,444
-50.2%
160,208
-33.8%
0.00%0.0%
Q4 2022$1,305,941
-20.9%
241,841
+46.9%
0.00%
-50.0%
Q3 2022$1,651,000
+1797.7%
164,642
+786.3%
0.00%
Q2 2022$87,000
-53.7%
18,577
-61.4%
0.00%
Q1 2022$188,000
+2.2%
48,176
+77.3%
0.00%
Q4 2021$184,000
-32.4%
27,167
+48.3%
0.00%
Q3 2021$272,00018,3140.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders